Identifying metabolic alterations in newly diagnosed small cell lung cancer patients

BACKGROUND: Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is based on imaging, histopathology, and immunohistochemistry, but no blood-based biomarkers have yet proven to be clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Shona, Hansen, Joachim Bavnhøj, Maltesen, Raluca Georgiana, Szejniuk, Weronika Maria, Andreassen, Trygve, Falkmer, Ursula, Kristensen, Søren Risom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the Clinical Metabolomics Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455369/
https://www.ncbi.nlm.nih.gov/pubmed/34585134
http://dx.doi.org/10.1016/j.metop.2021.100127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455369/
https://www.ncbi.nlm.nih.gov/pubmed/34585134
http://dx.doi.org/10.1016/j.metop.2021.100127

Ejemplares similares